Summary
The very low density lipoprotein (VLDL) fraction was isolated from 11 normolipidaemic Type 1 (insulin-dependent) diabetic patients in good to fair glycaemic control and from 11 age-, sex- and race-matched, non-diabetic, control subjects. The rate of receptor-mediated degradation by human endothelial cells was significantly greater (p<0.02) for the total VLDL fraction isolated from diabetic patients compared to control subjects and averaged 1008±300 and 717±150 ng·mg cell protein−1·16 h−1, respectively. The total VLDL fraction was separated into three subfractions: VLDL-I, Sf 100–400 (Sf = Svedberg units); VLDL-II, Sf 60–100; VLDL-III, Sf20–60. Rates of receptor-mediated degradation of VLDL-I and VLDL-II isolated from diabetic patients were significantly greater than the comparable subfraction isolated from control subjects and averaged 1023±279 vs 361±122 (p<0.01) and 433±70 vs 294±70 ng·mg cell protein−1·16 h−1 (p<0.03), respectively. Rates of receptor-mediated degradation of the V-III subfraction isolated from the two groups did not differ significantly. There were no significant differences in the chemical composition or in the plasma concentrations of the VLDL subfractions isolated from diabetic patients compared to control subjects. There was a significant increase in the apoprotein E content of VLDL-I (p<0.01) and VLDL-II (p<0.05) isolated from diabetic patients. There was a significant increase in the ratio of apoprotein C compared to apoprotein E (p<0.03) in VLDL-I isolated from control subjects compared to the diabetic patients. There were no significant differences in the apoprotein composition of VLDL-III isolated from the two groups.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
West KM (1982) Hyperglycemia as a cause of long-term complications. In: Keen H, Jarrett RJ (eds) Complications of diabetes. Edward Arnold, London, pp 13–18
Garcia MJ, McNamara PM, Gordon T, Kannel WB (1974) Morbidity and mortality in diabetes in the Framingham population. Diabetes 23: 105–111
Barrett-Conner E, Orchard T (1985) Diabetes and heart disease. In: Harris ME, Hamman RF (eds) National diabetes data group, diabetes in America. National Institutes of Health Publication No. 85-1468. U. S. Department of Health and Human Services, Washington, DC, pp 63–69
Lopes-Virella MF, Sherer GK, Lees AM et al. (1982) Surface binding, internalization, and degradation by cultured human fibroblasts of low density lipoproteins isolated from type 1 (insulin-dependent) diabetic patients: changes with metabolic control. Diabetologia 22: 430–436
Kraemer FB, Chen Y-DI, Cheung RMC, Reaven GM (1982) Are the binding and degradation of low density lipoprotein altered in type 2 (non-insulin-dependent) diabetes mellitus? Diabetologia 23: 28–33
Hiramatsu K, Bierman EL, Chait A (1985) Metabolism of low density lipoprotein from patients with diabetic hypertriglyceridemia by cultured human skin fibroblasts. Diabetes 34: 8–14
Lopes-Virella MF, Klein RL, Lyons TJ, Stevenson HC, Witztum JL (1988) Glycation of low-density lipoproteins enhances cholesteryl ester synthesis in human monocyte macrophages. Diabetes 37: 550–557
Lyons TJ, Klein RL, Baynes JW, Stevenson HC, Lopes-Virella MF (1987) Stimulation of cholesteryl ester synthesis in human monocyte-derived macrophages by low-density lipoproteins from type 1 (insulin-dependent) diabetic subjects: the influence of non-enzymatic glycosylation of low-density lipoproteins. Diabetologia 30: 916–923
Klein RL, Lyons TJ, Lopes-Virella MF (1989) Interaction of VLDL isolated from type 1 (insulin-dependent) diabetic subjects with human monocyte derived macrophages. Metabolism 38: 1108–1114
Klein RL, Lyons TJ, Lopes-Virella MF (1990) Metabolism of very low-and low-density lipoproteins isolated from normolipidaemic type 2 (non-insulin-dependent) diabetic patients by human monocyte-derived macrophages. Diabetologia 33: 299–305
Kraemer FB, Chen Y-DI, Lopez RD, Reaven GM (1985) Effects of non-insulin-dependent diabetes mellitus on the uptake of very low density lipoproteins by thioglycolate-elicited mouse peritoneal macrophages. J Clin Endocrinol Metab 61: 335–342
Coetzee GA, Stein O, Stein Y (1979) Uptake and degradation of low density lipoproteins (LDL) by confluent, contact-inhibited bovine and human endothelial cells exposed to physiological concentrations of LDL. Atherosclerosis 33: 425–431
van Hinsbergh VW, Havekes L, Emies JJ, van Corven E, Scheffer M (1983) Low density lipoprotein metabolism by endothelial cells from human umbilical cord arteries and veins. Arteriosclerosis 3: 547–559
Baker DP, van Lenten BJ, Fogelman AM, Edwards PA, Kean C, Berliner JA (1984) LDL, scavenger, and beta-VLDL receptors on aortic endothelial cells. Arteriosclerosis 4: 248–255
Kume N, Arai H, Kawai C, Kita T (1991) Receptors for modified low-density lipoproteins on human endothelial cells: different recognition of acetylated low-density lipoprotein and oxidized low-density lipoprotein. Biochim Biophys Acta 1091: 63–67
Schleicher E, Deufeland T, Wieland OH (1981) Non-enzymatic glycosylation of human serum lipoproteins. Elevated ε3-lysine glycosylated low density lipoprotein in diabetic subjects. FEBS Lett 124: 1–4
Curtiss LK, Witztum JL (1985) Plasma apolipoproteins A-I, A-II, B, C-I and E are glucosylated in hyperglycemic diabetic subjects. Diabetes 34: 452–461
James RW, Pometta D (1990) Differences in lipoprotein subfraction composition and distribution between type 1 diabetic men and control subjects. Diabetes 39: 1158–1164
National diabetes data group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28: 1039–1057
Jaffe EA, Hoyer LW, Nachman RL (1973) Synthesis of antihemophiliac factor by cultured human endothelial cells. J Clin Invest 52: 2757–2767
Lindgren FT, Jensen LC, Hatch FT (1972) The isolation and quantitative analysis of serum lipoproteins. In: Nelson GJ (ed) Blood lipids and lipoproteins: quantitation, composition and metabolism. Wiley-Interscience, New York, pp 181–274
Folch J, Lees M, Stanley GHS (1957) A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226: 497–509
Ishikawa TT, McGee Y, Morrison JA, Glueck CJ (1974) Quantitative analyses of cholesterol in 5 to 20 μl of plasma. J Lipid Res 15: 286–291
Lipid Research Clinics Program (1974) Manual of lipid operations, Vol. 1. Lipid and lipoprotein analysis. National Institutes of Health, National Heart Lung and Blood Institute, Publication No. 75-628. US Government Printing Office, Washington, DC, pp 9–37
Bartlett GR (1959) Phosphorus assay in column chromatography. J Biol Chem 234: 466–468
Markwell MAK, Haas SM, Bieber LL, Tolbert NE (1978) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 87: 206–211
Ohkawa H, Ohishi N, Yagi K (1978) Reaction of linoleic acid hydroperoxide with thiobarbituric acid. J Lipid Res 19: 1053–1057
Smith SJ, Cooper GR, Henderson LO et al. (1987) Apolipoprotein standardization collaborating group: an international collaborative study on standardization of apolipoproteins A-I and B. Part I. Evaluation of a lyophilized candidate reference and calibration material. Clin Chem 33: 2240–2249
Henderson LO, Hannon WH, Smith SJ et al. (1987) An international collaborative study on standardization of apolipoproteins A-I and B. Part II. Evaluation of contributions of antisera to among-laboratory variance components. Clin Chem 33: 2250–2256
Falco JM, Schonfeld G, Witztum JL, Kolar JB, Weidman SW, Steelman R (1980) Effects of diet on apoprotein E levels and on the apoprotein E subspecies in human plasma lipoproteins. J Clin Endocrinol Metab 50: 521–528
Campos E, Makajima K, Tanaka A, Havel RJ (1992) Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100. J Lipid Res 33: 369–380
Kadish AH, Little RL, Steinberg JC (1986) A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. Clin Chem 14: 116–131
Lopes-Virella MF, Stone P, Ellis S, Colwell JA (1977) Cholesterol determination in high density lipoproteins separated by three different methods. Clin Chem 23: 882–884
Weisweiler P, Schwandt P (1978) Type 1 (insulin-dependent) versus type 2 (non-insulin-dependent) diabetes mellitus: characterization of serum lipoprotein alterations. Eur J Clin Invest 17: 87–91
Klein RL, Lopes-Virella MF (1992) Influence of glycemic control on the interaction of very low and low density lipoproteins isolated from type 1 (insulin-dependent) diabetic patients with human monocyte-derived macrophages. Diabetes 41: 1301–1307
Gianturco SH, Gotto AM Jr, Jackson RL et al. (1978) Control of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by very low density lipoproteins of subjects with hypertriglyceridemia. J Clin Invest 61: 320–328
Wang-Iverson P, Ginsberg HN, Peteanu LA, Le N-A, Brown WV (1985) Apo E-mediated uptake and degradation of normal very low density lipoproteins by human monocyte/macrophages: a saturable pathway distinct from the LDL receptor. Biochem Biophys Res Commun 126: 578–586
Innerarity TL, Arnold KS, Weisgraber KH, Mahley RW (1986) Apolipoprotein E is the determinant that mediates the receptor uptake of β very low density lipoproteins by mouse macrophages. Arteriosclerosis 6: 114–120
Mokuno H, Yamada N, Shimano H et al. (1991) The enhanced cellular uptake of very-low-density lipoprotein enriched in apolipoprotein E. Biochim Biophys Acta 1082: 63–70
Granot E, Eisenberg S (1990) ApoE-3-specific metabolism of human plasma very low density lipoproteins in cultured J-774 macrophages. J Lipid Res 31: 2133–2139
Gianturco SH, Gotto AM Jr, Hwang S-LC et al. (1983) Apolipoprotein E mediates uptake of SF 100–400 hypertriglyceridemic very low density lipoproteins by the low density lipoprotein receptor pathway in normal human fibroblasts. J Biol Chem 258: 4526–4533
Bradley WA, Hwang S-LC, Karlin JB et al. (1984) Low-density lipoprotein receptor binding determinants switch from apolipoprotein E to apolipoprotein B during the conversion of hypertriglyceridemic very-low-density lipoprotein to low-density lipoproteins. J Biol Chem 259: 14728–14735
Krul ES, Tikkanen MJ, Cole TG, Davie JM, Schonfeld G (1985) Role of apolipoproteins B and E in the cellular binding of very low density lipoproteins. J Clin Invest 75: 361–369
Krul ES, Tikkanen MJ, Schonfeld G (1988) Heterogeneity of apolipoprotein E epitope expression on human lipoproteins: importance for apolipoprotein E function. J Lipid Res 29: 1309–1325
Black SC, Hewett S, Kotubi Y, Brunt RV, Reckless JPD (1990) Isoform patterns of apolipoprotein E in diabetes mellitus. Diabetic Med 7: 532–539
Sano R, Abe R, Oikawa S-I, Fujii Y, Toyota T (1985) Apolipoprotein E2/E3 ratio of very low density lipoproteins in diabetes mellitus. Tohoku J Exp Med 146: 131–136
Eto M, Watanabe K, Iwashima Y et al. (1986) Apolipoprotein E polymorphism and hyperlipidaemia in type II diabetes. Diabetes 35: 1374–1382
James RW, Voliotis C, Grab B, Pometta D (1987) Apoprotein E (apo E) phenotype and serum lipids in diabetics. Schweiz Med Wochenschr 117: 2021–2023
Sitko-Rahm A, Wiman B, Hamsten A, Nilsson J (1990) Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein. Arteriosclerosis 10: 1067–1073
Booyse FM, Bruce R, Gianturco SH, Bradley WA (1988) Normal but not hypertriglyceridemic very low-density lipoprotein induces rapid release of tissue plasminogen activator from cultured human umbilical vein endothelial cells. Semin Thromb Hemost 14: 175–179
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Klein, R.L., Lopes-Virella, M.F. Metabolism by human endothelial cells of very low density lipoprotein subfractions isolated from Type 1 (insulin-dependent) diabetic patients. Diabetologia 36, 258–264 (1993). https://doi.org/10.1007/BF00399960
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00399960